Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Moodys
Mallinckrodt
Dow
Medtronic

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

FERRIC PYROPHOSPHATE CITRATE - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for ferric pyrophosphate citrate and what is the scope of patent protection?

Ferric pyrophosphate citrate is the generic ingredient in two branded drugs marketed by Rockwell Medical Inc and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric pyrophosphate citrate has thirteen patent family members in eleven countries.

There are twenty drug master file entries for ferric pyrophosphate citrate. Two suppliers are listed for this compound.

Summary for FERRIC PYROPHOSPHATE CITRATE
International Patents:13
US Patents:2
Tradenames:2
Applicants:1
NDAs:3
Drug Master File Entries: 20
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 10
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in FERRIC PYROPHOSPHATE CITRATE?FERRIC PYROPHOSPHATE CITRATE excipients list
DailyMed Link:FERRIC PYROPHOSPHATE CITRATE at DailyMed
Recent Clinical Trials for FERRIC PYROPHOSPHATE CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rockwell Medical Technologies, Inc.Phase 3
Rockwell Medical Technologies, Inc.Phase 2
Rockwell Medical Technologies, Inc.Phase 1/Phase 2

See all FERRIC PYROPHOSPHATE CITRATE clinical trials

Pharmacology for FERRIC PYROPHOSPHATE CITRATE

US Patents and Regulatory Information for FERRIC PYROPHOSPHATE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-002 Sep 4, 2015 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate FOR SOLUTION;INTRAVENOUS 208551-001 Apr 25, 2016 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Rockwell Medical Inc TRIFERIC AVNU ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 212860-001 Mar 27, 2020 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FERRIC PYROPHOSPHATE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 ⤷  Try it Free ⤷  Try it Free
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Merck
Medtronic
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.